II. Background
- Sodium Stibogluconate has been discontinued worldwide and is no longer available
- Use Meglumine Antimoniate (Glucantime) instead
III. Indications
IV. Mechanism
- Antimony (Sb) based Antiprotozoal with activity against Leishmaniasis
- Prodrug, reduced from pentavalent to trivalent form, interferes with Protozoal metabolic pathways
- Interacts with Protozoal trypanothione (thiol group) critical for its Redox Reactions
- Disrupts cellular processes resulting in cellular death
V. Dosing
- Precautions
- Dilute intravenous doses in 50 ml D5W or NS prior to administration
- Administer over >=10 minutes
-
Cutaneous Leishmaniasis
- Stibogluconate Sodium (Pentostam) 20 mg/kg/day for 20 days
-
Visceral Leishmaniasis
- Initial Course
- Adult: 10 mg/kg IV/IM daily for 20-30 days
- Child: 20 mg/kg IV/IM daily for 20-30 days
- Relapse
- Treat for 40-60 days
- Initial Course
VI. Adverse Effects
VII. Safety
- Pregnancy
- Avoid in pregnancy (suspected to be Teratogenic)
-
Lactation
- Likely safe in Lactation given low milk concentrations
- Consider avoiding Breast Feeding young infants (age <2 months) while taking Meglumine Antimoniate
- Monitoring: Baseline and weekly labs
VIII. Resources
IX. References
- Freedman (2025) Sanford Guide, accessed 7/13/2025 on IOS